a Global Innovative Platforms, Inc. division (GIPL)

Revolutionizing Animal Health through Breath Analysis.

Mission:

To lead the way in breath analytic diagnostics by creating the first breath test for animals, starting with heartworm in dogs.  Our revolutionary technology will push to identify a wide range of animal health issues, from a myriad of diseases to toxic environmental conditions.

Vision:

To set a new standard for animal health by providing non-invasive breath diagnostics that empower early detection, protect lives, and promote thriving environments.

Objective

Maximize Animal Wellness

Our objective is to become the leading provider of breath analytical tools for veterinarians on a global scale with implications and applications across professional, commercial, and residential markets.

We will strive to create a point-of-care breath test for a myriad of animal diseases starting with heartworm in dogs.  The entire panel of diseases can be tested with a single breath sample and provide immediate results.   Our AI software will continuously learn to maximize accuracy and improve results.

Our technology searches for different signals in the animal than most common tests look for.  This approach may greatly accelerate the detection of specific disease such as heartworm.  Common heartworm antigen tests, currently on the market, are not able to identify the disease until it has been present for about 6-7 months when the female adult heartworm becomes fully mature.

Early detection is key in treating most diseases.  Creating the earliest detection method allows solutions and treatment enacted to maximize results and minimize harm as well as financial losses.

The technology can be customized to identify specific problems across multiple animal related applications.

Potential

Technology, Artificial Intelligence, and Applications

Our gas chromatography technology can be utilized to identify many types of animal related problems in their earliest onset, which allows users to minimize financial and commercial losses, with no invasive testing.

Our proprietary breath analysis protocol allows for the identification of a myriad of animal diseases through a single breath sample. A single breath sample will be able to indicate the abnormality, a list of medications needed to aid in recovery, and if any antibiotic resistance is presence in the animal. The technology is quantitative, which allows the user to determine effectiveness of treatment by performing the breath test at different time intervals.

A separate application of our technology can be utilized to constantly monitor animal environments to identify dangerous conditions stemming from a wide range of sources.

Our Vocam Plus can read parts per trillion, making it the most sensitive and specific tool in the industry. Technology of this magnitude has not been available until recently.

Our unique processes can help prevent many problems before they begin.  Users can be automatically notified on a smart device when safe thresholds are exceeded.

Our AI software continuously learns in order to improve accuracy, results, and it’s potential list of applications.

Our Story

Management Experience and Credentials

The GIPL Management Team has proven credentials in a wide variety of technologies, product development, and operations ranging from Medical Technology, Genetics, Electronics, Product Manufacturing and Marketing, among others.

Our team is comprised of top veterinarians, parasitologists, and industry veterans who bring decades of experience to the table across product launch, industrial design, medical testing, food and beverage and more. Our leadership team has a history of starting and leading companies to successful exits.

Animal Health Issues

With 90 million companion dogs in the U.S. alone, many diseases are routinely tested for in order to maximize early detection.

The American Heartworm Society recommends that dogs are tested for heartworm at six months of age and every year thereafter for proper care. canine heartworm disease is a serious and potentially fatal disease of the heart and lungs of dogs worldwide. Cases have been increasing drastically over the past ten years. Current heartworm Antigen tests on the market cannot detect heartworm until it has matured for at least six (6) months. Our revolutionary breath test searches for different signals in the body that may result in significant earlier detection.

We will utilize our gas chromatography technology to test for heartworm though a breath sample. The same process can be used to identify a myriad of animal disease through a single  breath sample. Compromised animal environments can be a problem for a variety of reasons. Swine Flu is one of many air borne viruses that spread throughout animal populations quickly. Our gas chromatography technology can be utilized to identify these types of problems at their earliest onset to minimize losses.

We will be researching additional diseases to determine if we can create appropriate “prints”, upon successful completion of our initial “Heartworm Breath Print”. Fecal tests are commonly used for other parasitic diseases such as hookworms, roundworms, whipworms, and tapeworms; which are all common in dogs. Aside from the displeasure of pet owners and veterinarians dealing with stool samples; the accuracy and processes leave much to be desired.  Adding these types of diseases to a complete panel could provide a progressive alternative to working with stool samples.

Timeline & Milestones

At this time, no regulatory agencies are required to oversee our core business.